Edward Schuchman

Search results

• Startup Spotlight: New biopharma targets rare diseases with $35M in backing from NovaQuest

  Schuchman, E.

  3/05/21

  1 item of Media coverage

  Press/Media

• Focused On Rare Illnesses, NC Startup Aceragen Goes After Farber Disease

  Schuchman, E.

  2/05/21

  1 item of Media coverage

  Press/Media

• Fifth Annual Mount Sinai Innovation Awards

  Bernstein,, E., Simonaro, C., Sieh, W., Hubmacher,, D., Schuchman, E., Feingold, J., Ranti, D., Sanchez, R., Costa, A., Gorbenko, K., Coca, S., Margolies, L., Berenstein,, A., Rosen, R. & Oxley, T.

  25/11/19

  1 item of Media coverage

  Press/Media

• Researchers Work to Repurpose Drug to Battle Rare MPS Diseases

  Simonaro, C. & Schuchman, E.

  22/01/19

  1 item of Media coverage

  Press/Media

• Researchers Work to Repurpose Drug to Battle Rare MPS Diseases

  Simonaro, C. & Schuchman, E.

  22/01/19

  1 item of Media coverage

  Press/Media

• Mount Sinai joins with Paradigm and ReqMed to repurpose drug for treatment of MPS

  Simonaro, C. & Schuchman, E.

  21/01/19

  1 item of Media coverage

  Press/Media

• Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases

  Simonaro, C. & Schuchman, E.

  20/01/19

  1 item of Media coverage

  Press/Media

• PARADIGM BIOPHARMACEUTICALS : Mount Sinai Partners With Paradigm Biopharmaceuticals Ltd., ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases

  Simonaro, C. & Schuchman, E.

  19/01/19

  2 items of Media coverage

  Press/Media

• PARADIGM BIOPHARMACEUTICALS : Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases

  Simonaro, C. & Schuchman, E.

  19/01/19

  1 item of Media coverage

  Press/Media

• Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases [Sudan Tribune]

  Simonaro, C. & Schuchman, E.

  19/01/19

  1 item of Media coverage

  Press/Media

• Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases; The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate

  Simonaro, C. & Schuchman, E.

  18/01/19

  2 items of Media coverage

  Press/Media

• Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases; The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate

  Simonaro, C. & Schuchman, E.

  18/01/19

  1 item of Media coverage

  Press/Media

• Mount Sinai Partners With Paradigm Biopharmaceuticals Ltd., ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases

  Simonaro, C. & Schuchman, E.

  18/01/19

  1 item of Media coverage

  Press/Media

• Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed...

  Simonaro, C. & Schuchman, E.

  18/01/19

  3 items of Media coverage

  Press/Media

• Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases

  Simonaro, C. & Schuchman, E.

  18/01/19

  6 items of Media coverage

  Press/Media

• Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases

  Simonaro, C. & Schuchman, E.

  18/01/19

  1 item of Media coverage

  Press/Media

• Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases.

  Simonaro, C. & Schuchman, E.

  18/01/19

  1 item of Media coverage

  Press/Media

• Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases

  Simonaro, C. & Schuchman, E.

  18/01/19

  5 items of Media coverage

  Press/Media